In a case of Cryptococcal meningitis, which medications are typically administered?

In the management of Cryptococcal meningitis, the standard treatment involves the use of intravenous Amphotericin B along with Flucytosine. Amphotericin B is a polyene antifungal that effectively penetrates the central nervous system and acts by binding to ergosterol in fungal cell membranes, leading to cell death. Flucytosine is an antimetabolite that works synergistically with Amphotericin to enhance the antifungal effect and decrease the risk of resistance. This combination is particularly important in treating serious infections like Cryptococcus neoformans.

The initial treatment regimen typically lasts for at least two weeks before transitioning to maintenance therapy with Fluconazole. While Fluconazole is also an effective antifungal for Cryptococcus, it is generally not used as the first-line treatment in moderate to severe cases of cryptococcal meningitis on its own, especially in immunocompromised patients, where a more aggressive initial approach is warranted.

The other options do not represent the appropriate combination for treating Cryptococcal meningitis. For instance, Ceftriaxone, while a broad-spectrum cephalosporin, is not effective against fungi. Dapsone and Atovaquone are used for treating some parasitic infections